Proactive Investors - Run By Investors For Investors

LexaGene Holdings tackles rapid pathogen detection

LexaGene Holdings (CVE:LXG) President Daryl Rebeck tells Proactive Investors about how the biotech company continues to develop and commercialize pathogen detection devices in the biochemical industry.

Rebeck says pathogens are anything that can make us ill, such as salmonella, E. coli, respiratory diseases, Lyme disease. The instrument LexaGene offers quickly detects multiple pathogens with sensitivity and specificity.

"It's a very easy-to-use instrument," says Rebeck.

The platform could be used in food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and other markets.

View full LXG profile View Profile

Lexagene Holdings Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use